# Regadenoson

NDC: 72611-874
Generic name: Regadenoson
Labeler / Manufacturer: Almaject, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230703

FDA application: ANDA207320

## Active ingredients

- REGADENOSON: .08 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72611-874"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72611-874
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=991f6634-2d5c-6ceb-4bee-22fd144a6ff7